Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Guilherme Rabinowits

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Guilherme Rabinowits

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Annals of Oncology
Volume	30
State	Published - Mar 1 2019

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{fdb4682384c2445d9da4bd6f84222a7f,

title = "Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma",

author = "Guilherme Rabinowits",

note = "Annals of Oncology (2019) 30(3):471-477",

year = "2019",

month = mar,

day = "1",

language = "American English",

volume = "30",

journal = "Annals of Oncology",

}

TY - JOUR

T1 - Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

AU - Rabinowits, Guilherme

N1 - Annals of Oncology (2019) 30(3):471-477

PY - 2019/3/1

Y1 - 2019/3/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3032

M3 - Article

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Access to Document

Other files and links

Cite this